STERIS STE Life Sciences: — Cost of Revenue
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by STERIS in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The official record: STERIS’s 10-Q, filed February 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about STERIS's life sciences: — cost of revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is STERIS's life sciences: — cost of revenue?
- STERIS (STE) reported life sciences: — cost of revenue of $65.6M in Q4 2025.
- What does life sciences: — cost of revenue mean?
- This metric captures the direct costs associated with producing and delivering the products and services within the Life Sciences segment. It includes raw materials, direct labor, and manufacturing overhead required to support sterilization and decontamination equipment sales.